Major Drivers Propelling the Growth oh the Prostate Cancer Diagnostics Market Forward: Global Surge In Prostate Cancer Cases Drives Expansion Of Prostate Cancer Diagnostics Market
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Prostate Cancer Diagnostics Market From 2025 To 2029?
The market for prostate cancer diagnostics has seen a significant rise in size in the past few years. The market is projected to expand from $4.43 billion in 2024 to $5.02 billion in 2025, growing at a compound annual growth rate (CAGR) of 13.3%. The historical period’s growth is associated with factors such as an increasing elderly population, advancements in the field of medical imaging, elevated awareness and screening programs, public health actions, and improved biopsy methods.
The market size of prostate cancer diagnostics is predicted to experience accelerated expansion in the forthcoming years, reaching$8.13 billion by 2029 with a compound annual growth rate (CAGR) of 12.8%. The rapid growth during the forecast period is due to the inclusion of artificial intelligence (AI), the rise of telemedicine in cancer detection, advancements in genomic profiling, patient-oriented strategies, and the utilization of multiparametric MRI in diagnosis. Numerous trends within the forecast duration include liquid biopsy technologies, progress in biomarker detection technology, clinical research and development, the incorporation of digital pathology, and the advent of multiplex biomarker assays.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12003&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Prostate Cancer Diagnostics Market?
The rising instances of prostate cancer are anticipated to boost the expansion of the prostate cancer diagnostics market. Prostate cancer occurs in the prostate gland, an element of both male and female reproductive systems. Assessments related to prostate cancer, like the prostate-specific antigen (PSA) test and advanced imaging methods, aid early diagnosis of the disease. For example, the American Cancer Society (ACS), a non-profit organization based in the US that’s focused on cancer eradication, reported around 288,300 fresh cases of prostate cancer and 34,700 deaths caused by prostate cancer in January 2023. Thus, the escalating cases of prostate cancer are likely to drive the prostate cancer diagnostics market’s growth.
Which Key Market Segments Comprise the Prostate Cancer Diagnostics Market and Drive Its Revenue Growth?
The prostate cancer diagnosticsmarket covered in this report is segmented –
1) By Products: Instruments; Reagents And Consumables; Accessories
2) By Test Type: Preliminary Tests; Confirmatory Tests
3) By Prostate Cancer: Squamous Cell Cancer; Small Cell Carcinoma; Transitional Cell Cancer; Prostatic Adenocarcinoma; Ductal Adenocarcinoma; Small Cell Prostate Cancer; Acinar Adenocarcinoma
4) By Peer Groups: Adult; Pediatric; Geriatrics
5) By End User: Hospitals; Independent Diagnostic Laboratories; Cancer Research Institutes; Other End-Users
Subsegments:
1) By Instruments: Biopsy Instruments; Imaging Devices; Digital Rectal Examination Tools
2) By Reagents And Consumables: Diagnostic Assay Kits; Staining Reagents; Sample Collection Materials
3) By Accessories: Biopsy Guides; Specimen Handling Accessories; Calibration And Maintenance Tools
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12003&type=smp
Which Areas Are Leading Regions in the Prostate Cancer Diagnostics Market Expansion Across the Globe?
North America was the largest region in the prostate cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theProstate Cancer Diagnostics Market Over the Coming Years?
Technological advancements are becoming an increasingly prominent trend within the prostate cancer diagnostics market. Major businesses within this sector are launching innovative AI-based tools for prostate cancer diagnosis in a bid to maintain their market dominance. For example, in March 2023, Qritive, a company from Singapore that specializes in diagnostic tools, launched QAi Prostate, a sophisticated AI tool for diagnosing prostate cancer, specifically for pathologists. This tool utilises cutting-edge machine learning algorithms to pinpoint the prostatic adenocarcinoma area and scrutinise whole slide images of prostate core needle biopsies. It consequently aids pathologists in swiftly making accurate diagnoses and reduces the overall treatment time.
View the full report here:
https://www.thebusinessresearchcompany.com/report/prostate-cancer-diagnostics-global-market-report
How Is the Prostate Cancer Diagnostics Market Conceptually Defined?
Prostate cancer diagnostics refers to the process of determining and verifying the presence of prostate cancer using diagnostic testing and medical evaluations to evaluate the status and severity of the illness and direct treatment choices. It is commonly used to treat prostatic adenocarcinoma, transitional cell carcinomas, and neuroendocrine tumors.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12003
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
